Executives
-
Guindo ChirfiChief Marketing Officer -
Smart DaltonSVP Fin. - Global Controller
-
Deluca Richard R.EVP&Pres, Merck Animal Heallth
-
Oosthuizen Johannes JacobusPresident, U.S. Market
-
Larson Betty DEVP, Chief HR Officer
-
Downing Cristal NChief Comm. & Public Afrs Ofcr
-
Zachary JenniferEVP, General Counsel
-
Li Dean YExecutive VP & President, MRL
-
Davis Robert MChairman, CEO & President
-
Chattopadhyay SanatExe V-P & Pres. MMD
-
Williams David MichaelEVP,Chief Info&Digital Officer
-
Litchfield CarolineEVP & CFO
-
Mizell StevenEVP, Chief HR Officer
?
Li Dean Y
Executive VP & President, MRL
Merck & Co., Inc.
US, Kenilworth [HQ]
CIK
1837016
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
4,624,237
Price per Share :
$100.03
Equivalence :
$462,562,427.11
Transaction History
-
A4,624,237 Shares After TransactionValue : $552,272,624.91$3,076,516.80Transaction Date : 01/22/24
-
Footnotes
-
-
Footnotes:#1 Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/21. Performance shares were paid out at 161 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2023.#2 Holdings include shares acquired in dividend reinvestment transactions.
-
M6,094,437 Shares After TransactionValue : $378,281,704.59$912,553.14Transaction Date : 02/09/24
-
Footnotes
-
-
Footnotes:#1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.4900 to $125.5330, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.#2 Holdings include shares acquired in dividend reinvestment transactions.
-
S4,624,237 Shares After TransactionValue : $580,341,743.50Sold $1,845,101.00Transaction Date : 02/09/24
-
Footnotes
-
-
Footnotes:#1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.4900 to $125.5330, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.#2 Holdings include shares acquired in dividend reinvestment transactions.